Cargando…

Cascade Screening in Familial Hypercholesterolemia: Achieving Buy-In and Turning Patients Into Partners

Detalles Bibliográficos
Autor principal:	Khoury, Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10642102/ https://www.ncbi.nlm.nih.gov/pubmed/37970215 http://dx.doi.org/10.1016/j.cjcpc.2023.06.002

Ejemplares similares

Predictors of Family Recruitment in a Program of Genetic Cascade Screening for Familial Hypercholesterolemia
por: Izar, Maria Cristina de Oliveira, et al.
Publicado: (2018)

Cascade Screening for Familial Hypercholesterolemia (FH)
por: Ned, Renée M., et al.
Publicado: (2011)

Stakeholder Views on Active Cascade Screening for Familial Hypercholesterolemia
por: van El, Carla G., et al.
Publicado: (2018)

Genetic variations in familial hypercholesterolemia and cascade screening in East Asians
por: Chan, Melody Lok‐Yi, et al.
Publicado: (2018)

CASCADE screening and registry of familial hypercholesterolemia in Iran: Rationale and design
por: Vaseghi, Golnaz, et al.
Publicado: (2019)

Finding Importance for Universal Screening of Familial Hypercholesterolemia
por: Yokoyama, Shinji
Publicado: (2022)

Predictors of Family Enrollment in a Genetic Cascade Screening Program for Familial Hypercholesterolemia
por: Silva, Pãmela Rodrigues de Souza, et al.
Publicado: (2018)

Cascade Screening and Treatment Initiation in Young Adults with Heterozygous Familial Hypercholesterolemia
por: Peterson, Amy L., et al.
Publicado: (2021)

Phenotypic vs. genetic cascade screening for familial hypercholesterolemia: A case report
por: Blokhina, Anastasia V., et al.
Publicado: (2022)

Genetic Spectrum and Cascade Screening of Familial Hypercholesterolemia in Routine Clinical Setting in Hong Kong
por: Yip, Man-Kwan, et al.
Publicado: (2023)

Long‐Term Cardiovascular Risk in Heterozygous Familial Hypercholesterolemia Relatives Identified by Cascade Screening
por: Kjærgaard, Kasper Aalbæk, et al.
Publicado: (2017)

The Draupadi of dyslipidemia: Familial hypercholesterolemia
por: Kalra, Sanjay, et al.
Publicado: (2016)

Recall by genotype and cascade screening for familial hypercholesterolemia in a population-based biobank from Estonia
por: Alver, Maris, et al.
Publicado: (2018)

Developing and Optimizing Innovative Tools to Address Familial Hypercholesterolemia Underdiagnosis: Identification Methods, Patient Activation, and Cascade Testing for Familial Hypercholesterolemia
por: Campbell-Salome, Gemme, et al.
Publicado: (2021)

What Arteries are Affected in Familial Hypercholesterolemia?
por: Harada-Shiba, Mariko
Publicado: (2019)

Premature Coronary Artery Disease and Familial Hypercholesterolemia: Need for Early Diagnosis and Cascade Screening in the Indian Population
por: Setia, N., et al.
Publicado: (2012)

A proof-of-concept study of cascade screening for Familial Hypercholesterolemia in the US, adapted from the Dutch model
por: McGowan, Mary P., et al.
Publicado: (2021)

If You Contemplate Buying an Automobile
Publicado: (1915)

Hypercholesterolemia Diagnosis, Treatment Patterns, and 12-Month Target Achievement in Clinical Practice in Germany in Patients with Familial Hypercholesterolemia
por: Gitt, Anselm K., et al.
Publicado: (2022)

Successful Treatment of Homozygous Familial Hypercholesterolemia Using Cascade Filtration Plasmapheresis
por: Kardaş1, Fatih, et al.
Publicado: (2012)

Putting Into Perspective the Hazards of Untreated Familial Hypercholesterolemia
por: Hopkins, Paul N.
Publicado: (2017)

Design of a Controlled Trial of Cascade Screening for Hypercholesterolemia: The (CASH) Study
por: Kullo, Iftikhar J., et al.
Publicado: (2018)

The Roles of Genetic Analysis in the Diagnosis of Pediatric Patients with Familial Hypercholesterolemia
por: Harada-Shiba, Mariko
Publicado: (2022)

Identifying familial hypercholesterolemia in an early onset ischemic cerebrovascular disease patient and the cascade screening in the pedigree: a case report
por: Yuan, Yuan, et al.
Publicado: (2021)

Cascade screening for familial hypercholesterolemia-identification of the C308Y mutation in multiple family members and relatives for the first time in mainland China
por: Jin, Weirong, et al.
Publicado: (2019)

Impact of Familial Hypercholesterolemia Diagnosis in Real-World Data
por: Harada-Shiba, Mariko
Publicado: (2023)

Autosomal Dominant Hypercholesterolemia: Needs for Early Diagnosis and Cascade Screening in the Tunisian Population
por: Jelassi, Awatef, et al.
Publicado: (2013)

Is the tide turning against breast screening?
por: Jørgensen, Karsten Juhl
Publicado: (2012)

Genetics, Screening, and Treatment of Familial Hypercholesterolemia: Experience Gained From the Implementation of the Vietnam Familial Hypercholesterolemia Registry
por: Truong, Thanh-Huong, et al.
Publicado: (2020)

Genetic screening for homozygous and heterozygous familial hypercholesterolemia
por: Izar, Maria C, et al.
Publicado: (2010)

Contemporary Homozygous Familial Hypercholesterolemia in the United States: Insights From the CASCADE FH Registry
por: Cuchel, Marina, et al.
Publicado: (2023)

Negative impact of COVID-19 pandemic on the lifestyle and management of patients with homozygous familial hypercholesterolemia
por: Kayikcioglu, Meral, et al.
Publicado: (2020)

Opportunistic Genetic Screening for Familial Hypercholesterolemia in Heart Transplant Patients
por: Salgado, María, et al.
Publicado: (2023)

Designing implementation strategies to improve identification, cascade testing, and management of families with familial hypercholesterolemia: An intervention mapping approach
por: Jones, Laney K., et al.
Publicado: (2023)

Web-Based Tool (FH Family Share) to Increase Uptake of Cascade Testing for Familial Hypercholesterolemia: Development and Evaluation
por: Bangash, Hana, et al.
Publicado: (2022)

Optimizing communication strategies and designing a comprehensive program to facilitate cascade testing for familial hypercholesterolemia
por: Campbell-Salome, Gemme, et al.
Publicado: (2023)

Correction to: Contemporary Homozygous Familial Hypercholesterolemia in the United States: Insights from the CASCADE FH Registry
Publicado: (2023)

Cost-effectiveness of cascade genetic testing for familial hypercholesterolemia in the United States: A simulation analysis
por: Jackson, Candace L., et al.
Publicado: (2021)

Familial Hypercholesterolemia and Elevated Lipoprotein(a): Cascade Testing and Other Implications for Contextual Models of Care
por: Loh, Wann Jia, et al.
Publicado: (2022)

Motivating cascade testing for familial hypercholesterolemia: applying the extended parallel process model for clinician communication
por: Campbell-Salome, Gemme, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_56d3anj6nbfms0sna0bjo3li2m